Free shipping on all orders over $ 500

Zafirlukast

Cat. No. M3548

All AbMole products are for research use only, cannot be used for human consumption.

Zafirlukast Structure
Synonym:

ICI 204219

Size Price Availability Quantity
100mg USD 95  USD95 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Zafirlukast is in a class of medications called leukotriene receptor antagonists (LTRAs). It works by blocking the action of certain natural substances that cause swelling and tightening of the airways. In a study, pranlukast or zafirlukast significantly inhibited 10 μM LTD4-evoked 35SO4 output in a concentration- dependent fashion, with maximal inhibitions of 83% at 10 μM pranlukast and 78% at 10 μM zafirlukast, and IC50 values of 0.3 μM for pranlukast and 0.6 μM for zafirlukast. Both pranlukast and zafirlukast showed moderate inhibition of CYP2C9-catalysed tolbutamide 4-methylhydroxylation, competitively inhibiting tolbutamide 4-methylhydroxylation with estimated mean Ki values of 3.82 ± 0.50 and 5.86 ± 0.08 μM, respectively.Zafirlukast inhibited the hydroxylation of tolbutamide (CYP2C9; mean IC50=7.0 µM).

Chemical Information
Molecular Weight 575.68
Formula C31H33N3O6S
CAS Number 107753-78-6
Form Solid
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Qiang Song, et al. Zafirlukast prevented ox-LDL-induced formation of foam cells

[2] Amareen Dhaliwal, et al. Zafirlukast

[3] No authors listed. Zafirlukast

[4] No authors listed. Zafirlukast

[5] Joyce A Generali, et al. Zafirlukast: Chronic Urticaria

Related Leukotriene Receptor Products
Pranlukast

Pranlukast is a selective cysteinyl leukotriene receptor antagonist.

Cyclopentyl Chloroformate

Mandelic acid derivatives and their use as thrombin inhibitors.

LY255283

LY255283 is a competitive leukotriene B4 receptor antagonist, with an IC50 of about 100 nM.

CP-424174

CP-424174 is a cytokine release inhibitory compound (CRID) and also a reversible IL-1β inhibitor with an IC50 of 210 nM, which inhibits post-translational processing and secretion of IL-1β in human monocytes in the presence of LPS and ATP.

CP-105,696

CP-105,696 is an orally active, potent and selective leukotriene B4 receptor (LTB4R) antagonist (IC50 against [3H]LTB4 = 5.

  Catalog
Abmole Inhibitor Catalog




Keywords: Zafirlukast, ICI 204219 supplier, Leukotriene Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.